Xevudy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Xevudy, covering 2021-11-18 to 2026-03-04. Get the full timeline:
Most recent: EMA Withdrawn: Xevudy (sotrovimab) — GlaxoSmithKline Trading Services Limited